DFX Intelligence
Halda Therapeutics, LLC
Venture-backed company · Stage unknown· New Haven, CT
As of · the latest observation of this company; each round carries its own date
Form D industry: Other Health Care
As of · the latest observation of this company; each round carries its own date
4 additional officers and directors, 10 additional investors
Every relationship, signal and contact on this record, with the source on each.
Includes 3 days of DFX Intelligence. Then $199/month unless canceled.
What matters now
- Acquiredobserved
Acquired by Johnson & Johnson (seen on or before Sep 15, 2026).
seen on or before Sep 15, 2026 · A later owner ends or changes the venture chapter: new decision makers, new lenders, returns for the investors on record.
Factpress and portfolio pagesFor Investors, acquirers, lenders, service providersOwnership and outcomes → - 7 investorsnamed
7 investors on record.
The investors already on the cap table shape who leads the next round.
- 7 directorsboard
7 directors on record from Form D filings and board-seat attributions.
The board is who decides on the next round and on a sale.
Drawing the relationship network…
Facts
- Year of incorporation
- unknown
- Revenue range (Form D)
- Decline to Disclosesec.gov
- Rounds on record
- 4
- Disclosed raised
- unknownsum of rounds with a disclosed amount only
- Named investors
- 7
Financing history
4 rounds
- Jul 31, 2024Form D equity offering · $126M (form d sold) · 20 investorsCanaan Partners via TIM ShannonFrazier Life Sciences Management, LP via Joe CabralRA Capital Management, LP via Nandita ShangariVV Manager LLC via Arjun GoyalDeep Track Capital via Rebecca LuseFact Form D · “Halda Therapeutics, LLC filed Form D: $126,471,316 sold of $126,471,316, Other Health Care”
- May 21, 2024Form D equity offering · $24.2M (form d sold) · 9 investorsCanaan Partners via TIM ShannonFact Form D · “Halda Therapeutics, LLC filed Form D: $24,211,678 sold of $36,000,000, Other Health Care”
- Dec 1, 2021Form D equity offering · $41.0M (form d sold)Canaan Partners via TIM Shannon120 Capital via Leyi WangFact Form D · “Halda Therapeutics, LLC Form D, first filed 2021-12-10”
- Feb 22, 2019Form D equity offering · $6.3M (form d sold)Fact Form D
Investors on record
12 edges
- Canaan Partners portfolio listingAcquired Fact canaan.com
- RA Capital Management, LP portfolio listing Fact racap.com
- Canaan Partners form d related, TIM Shannon (strongly supported) Inference sec.gov
Ownership and outcomes
How these are wordedA company a buyout or growth firm lists on its own site is “listed in the portfolio of”, never “acquired by”. A date prints only when a deal record gives one; otherwise the row says when DFX first saw it.1 on record, from the private equity graph and exit reports
Outcome stated by investors
Acquired by Johnson & Johnson, as 1 of 2 firm portfolio pages states it.
Date basis: the firm’s page was read Oct 1, 2026; DFX first saw this outcome Oct 1, 2026. This is when the page said it, not when the deal happened.
Evidence: 2 listingseach firm's own card, as read
- Acquired by Johnson & Johnson on Canaan Partners · the firm's card says acquired · read Oct 1, 2026 canaan.com“Halda Therapeutics Acquired by Johnson & Johnson”
- Status not stated on RA Capital Management, LP · the firm's card prints no outcome · read Oct 1, 2026 racap.com“Halda Therapeutics”
- Acquired by Johnson & Johnson · already an investor on record“Halda Therapeutics, LLC: acquired by Johnson & Johnson on or before 2026-09-15 (no date published), per Canaan Partners's portfolio page”
Credit relationships
How a loan is matchedA BDC reports its loans by borrower name. A position shows here only when the match passed a precision gate (a hand-labelled sample was 29 of 30 correct); the tier and confidence are printed on each row. Amounts are the lender’s reported position, never a round.none on record
No lender position matched to this company.
People
2 officers, 7 directors
- Scott Phillips Executive Officer sec.gov
- TIM Shannon Manager sec.gov
- Liam Ratcliffe Manager Fact
- Rebecca Frey Manager Fact
- Liam Ratcliffe Manager Fact
Timeline
3 events
- seen on or beforeSep 15, 2026Halda Therapeutics, LLC: acquired by Johnson & Johnson on or before 2026-09-15 (no date published), per Canaan Partners's portfolio pageAcquired Fact Firm website
- Aug 12, 2024Halda Therapeutics, LLC filed Form D: $126,471,316 sold of $126,471,316, Other Health CareForm D filed Fact Form D
- May 24, 2024Halda Therapeutics, LLC filed Form D: $24,211,678 sold of $36,000,000, Other Health CareForm D filed Fact Form D
Evidence
34 observations
Every observation on this company
- Entity type: Limited Liability Company Aug 12, 2024 Fact Form D
- Entity type: Limited Liability Company May 24, 2024 Fact Form D
- Form D industry group: Other Health Care Aug 12, 2024 Fact Form D
- Form D industry group: Other Health Care May 24, 2024 Fact Form D
- Amendment: false Aug 12, 2024 Fact Form D
- Amendment: false May 24, 2024 Fact Form D
- Revenue range (Form D): Decline to Disclose Aug 12, 2024 Fact Form D
- Revenue range (Form D): Decline to Disclose May 24, 2024 Fact Form D
- Incorporated: overFiveYears Aug 12, 2024 Fact Form D
- Incorporated: overFiveYears May 24, 2024 Fact Form D
- Jurisdiction: Delaware Aug 12, 2024 Fact Form D
- Jurisdiction: Delaware May 24, 2024 Fact Form D
- Amount sold (Form D): $126M Aug 12, 2024 Fact Form D
- Amount sold (Form D): $24.2M May 24, 2024 Fact Form D
- Offering amount (Form D): $126M Aug 12, 2024 Fact Form D
- Offering amount (Form D): $36.0M May 24, 2024 Fact Form D
- Exemptions: 06b Aug 12, 2024 Fact Form D
- Exemptions: 06b May 24, 2024 Fact Form D
- First sale: 2024-07-31 Aug 12, 2024 Fact Form D
- First sale: 2024-05-21 May 24, 2024 Fact Form D
- Investors (Form D): 20 Aug 12, 2024 Fact Form D
- Investors (Form D): 9 May 24, 2024 Fact Form D
- Minimum investment (Form D): 0 Aug 12, 2024 Fact Form D
- Minimum investment (Form D): 0 May 24, 2024 Fact Form D
- Securities offered: equity Aug 12, 2024 Fact Form D
- Securities offered: Debt, option May 24, 2024 Fact Form D
- Office address: Aug 12, 2024 Fact Form D
- Office address: May 24, 2024 Fact Form D
- Listed on portfolio page: Oct 1, 2026 Fact
- Listed on portfolio page: Oct 1, 2026 Fact Firm website
- Listed on portfolio page: Sep 16, 2026 Fact
- Listed on portfolio page: Sep 16, 2026 Fact Firm website
- Listed on portfolio page: Sep 15, 2026 Fact
- Listed on portfolio page: Sep 15, 2026 Fact Firm website
Relationships across DFX
on 1 other DFX graph
Across the graphs
Halda Therapeutics, LLC is the same institution as 1 record in Private Equity.
Private Equity1
The joined record opens with the product, beside every other relationship on this page.
Checking your plan…
Record history
3 dated events on the change ledger, latest event first
- Acquired2026-09-15source on record
- Form D filed2024-08-12source on record
- Form D filed2024-05-24source on record
The ledger records every merge, rename and reclassification this record went through and the dated filings observed on it, so the identity on this page can be traced to the records it was built from. The ledger's own sentences name other records, so they show with the names.